Metage2Metabo, microbiota-scale metabolic complementarity for the identication of key species

  1. Arnaud Belcour
  2. Clémence Frioux  Is a corresponding author
  3. Méziane Aite
  4. Anthony Bretaudeau
  5. Falk Hildebrand
  6. Anne Siegel
  1. Univ Rennes, Inria, CNRS, IRISA, France
  2. Inria, France
  3. INRAE, UMR IGEPP, France
  4. Quadram Institute, United Kingdom

Abstract

To capture the functional diversity of microbiota, one must identify metabolic functions and species of interest within hundreds or thousands of microorganisms. We present Metage2Metabo (M2M) a resource that meets the need for de-novo functional screening of genome-scale metabolic networks (GSMNs) at the scale of a metagenome, and the identification of critical species with respect to metabolic cooperation. M2M comprises a flexible pipeline for the characterisation of individual metabolisms and collective metabolic complementarity. In addition, M2M identifies key species, that are meaningful members of the community for functions of interest. We demonstrate that M2M is applicable to collections of genomes as well as metagenome-assembled genomes, permits an efficient GSMN reconstruction with Pathway Tools, and assesses the cooperation potential between species. M2M identifies key organisms by reducing the complexity of a large-scale microbiota into minimal communities with equivalent properties, suitable for further analyses.

Data availability

Data for metabolic modelling is available in https://github.com/AuReMe/metage2metabo/tree/master/article_data .

The following previously published data sets were used

Article and author information

Author details

  1. Arnaud Belcour

    Dyliss, Univ Rennes, Inria, CNRS, IRISA, Rennes, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1170-0785
  2. Clémence Frioux

    Pleiade, Inria, Talence, France
    For correspondence
    clemence.frioux@inria.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2114-0697
  3. Méziane Aite

    Dyliss, Univ Rennes, Inria, CNRS, IRISA, Rennes, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Anthony Bretaudeau

    BioInformatics Platform for Agroecosystems Arthropods (BIPAA), INRAE, UMR IGEPP, Rennes, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Falk Hildebrand

    Quadram Institute, Norwich, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Anne Siegel

    Dyliss, Univ Rennes, Inria, CNRS, IRISA, Rennes, France
    Competing interests
    The authors declare that no competing interests exist.

Funding

BBSRC (Gut Microbes and Health BB/r012490/1,and its constituent project BBS/e/F/000Pr1035)

  • Clémence Frioux
  • Falk Hildebrand

2 (IDEALG (ANR-10-BTBR-04) Investissements d'Avenir)

  • Arnaud Belcour
  • Clémence Frioux
  • Méziane Aite

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. María Mercedes Zambrano, CorpoGen, Colombia

Version history

  1. Received: August 10, 2020
  2. Accepted: December 25, 2020
  3. Accepted Manuscript published: December 29, 2020 (version 1)
  4. Version of Record published: February 4, 2021 (version 2)

Copyright

© 2020, Belcour et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,355
    Page views
  • 550
    Downloads
  • 34
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Arnaud Belcour
  2. Clémence Frioux
  3. Méziane Aite
  4. Anthony Bretaudeau
  5. Falk Hildebrand
  6. Anne Siegel
(2020)
Metage2Metabo, microbiota-scale metabolic complementarity for the identication of key species
eLife 9:e61968.
https://doi.org/10.7554/eLife.61968

Share this article

https://doi.org/10.7554/eLife.61968

Further reading

    1. Cancer Biology
    2. Computational and Systems Biology
    Bingrui Li, Fernanda G Kugeratski, Raghu Kalluri
    Research Article

    Non-invasive early cancer diagnosis remains challenging due to the low sensitivity and specificity of current diagnostic approaches. Exosomes are membrane-bound nanovesicles secreted by all cells that contain DNA, RNA, and proteins that are representative of the parent cells. This property, along with the abundance of exosomes in biological fluids makes them compelling candidates as biomarkers. However, a rapid and flexible exosome-based diagnostic method to distinguish human cancers across cancer types in diverse biological fluids is yet to be defined. Here, we describe a novel machine learning-based computational method to distinguish cancers using a panel of proteins associated with exosomes. Employing datasets of exosome proteins from human cell lines, tissue, plasma, serum, and urine samples from a variety of cancers, we identify Clathrin Heavy Chain (CLTC), Ezrin, (EZR), Talin-1 (TLN1), Adenylyl cyclase-associated protein 1 (CAP1), and Moesin (MSN) as highly abundant universal biomarkers for exosomes and define three panels of pan-cancer exosome proteins that distinguish cancer exosomes from other exosomes and aid in classifying cancer subtypes employing random forest models. All the models using proteins from plasma, serum, or urine-derived exosomes yield AUROC scores higher than 0.91 and demonstrate superior performance compared to Support Vector Machine, K Nearest Neighbor Classifier and Gaussian Naive Bayes. This study provides a reliable protein biomarker signature associated with cancer exosomes with scalable machine learning capability for a sensitive and specific non-invasive method of cancer diagnosis.

    1. Computational and Systems Biology
    2. Immunology and Inflammation
    Alain Pulfer, Diego Ulisse Pizzagalli ... Santiago Fernandez Gonzalez
    Tools and Resources

    Intravital microscopy has revolutionized live-cell imaging by allowing the study of spatial–temporal cell dynamics in living animals. However, the complexity of the data generated by this technology has limited the development of effective computational tools to identify and quantify cell processes. Amongst them, apoptosis is a crucial form of regulated cell death involved in tissue homeostasis and host defense. Live-cell imaging enabled the study of apoptosis at the cellular level, enhancing our understanding of its spatial–temporal regulation. However, at present, no computational method can deliver robust detection of apoptosis in microscopy timelapses. To overcome this limitation, we developed ADeS, a deep learning-based apoptosis detection system that employs the principle of activity recognition. We trained ADeS on extensive datasets containing more than 10,000 apoptotic instances collected both in vitro and in vivo, achieving a classification accuracy above 98% and outperforming state-of-the-art solutions. ADeS is the first method capable of detecting the location and duration of multiple apoptotic events in full microscopy timelapses, surpassing human performance in the same task. We demonstrated the effectiveness and robustness of ADeS across various imaging modalities, cell types, and staining techniques. Finally, we employed ADeS to quantify cell survival in vitro and tissue damage in mice, demonstrating its potential application in toxicity assays, treatment evaluation, and inflammatory dynamics. Our findings suggest that ADeS is a valuable tool for the accurate detection and quantification of apoptosis in live-cell imaging and, in particular, intravital microscopy data, providing insights into the complex spatial–temporal regulation of this process.